Brief: Bioextrax Q4 Operating Loss Widens To SEK 5.8 Million
15/02/2023 07:42
Feb 15 (Reuters) - Bioextrax AB publ BIOEX.ST :
* Q4 NET SALES SEK 32,000 VERSUS SEK 183,000 YEAR AGO
* Q4 OPERATING LOSS SEK 5.8 MILLION VERSUS LOSS SEK 2.9
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN8H4Y7W
Further company coverage: BIOEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Bioextrax AB publ
See all newsBrief: Bioextrax And LTU Application Approved By Wallenberg Wood Science Center
Brief: Bioextrax Proposes Private Placement, Rights Issue Of Units Of SEK 10 Mln
Brief: Bioextrax Q2 Operating Loss SEK 4.9 Mln
Brief: Bioextrax Files Patent Application For PHA Fermentation Process Using Molasses
Brief: Bioextrax Signs Framework Agreement With Chemical Company